跳至主要内容
临床试验/JPRN-UMIN000006815
JPRN-UMIN000006815已完成3 期

Outcome study of Lanthanum Carbonate compared with Calcium carbonate on cardiovascular mortality and morbidity in patients with chronic kidney disease on hemodialysis: Landmark Study - Outcome study of Lanthanum Carbonate compared with Calcium carbonate in hemodialysis patients: Landmark Study

andmark Study Group0 个研究点目标入组 2,347 人开始时间: 2011年12月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
2,347

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • - contraindications to Ca carbonate and La carbonate - swallowing disorders - severe GI disorders - history of obstructed bowels - history of IHD/stroke within 6 months - NYHA classification III-IV - severe liver dysfunction, AST or ALT greater than 3 times the upper limit of institution - require treatment of arrthythmia - severe malnutrition - malignancy of any type within the last 5 years - peritoneal dialysis patients - pregnant or possibly pregnant women or women on lactation and plan to get pregnant within study term - ineligible patients according to the investigator's judgment

研究者

发起方
andmark Study Group

相似试验